Citations

Institution: Mayo Clinic Clear

Showing 10 of 108104 citations.

Glucagon-like peptide-1 receptor dimerization differentially regulates agonist signaling but does not affect small molecule allostery
Harikumar, Kaleeckal G. , Wootten, Denise , Pinon, Delia I., Koole, Cassandra, Ball, Alicja M., Furness, Sebastian G. B. , Graham, Bim , Dong, Maoqing , Christopoulos, Arthur , Sexton, Patrick M. , Miller, Laurence J. , Harikumar, Kaleeckal G

Proceedings of the National Academy of Sciences | October 23, 2012 | Volume: 109 | Issue: 45 | Pages: 18607-18612

10.1073/pnas.1205227109 | PMID 23091034 Get It

The glucagon-like peptide-1 receptor (GLP-1R) is a family B G protein-coupled receptor and an important drug target for the treatment of type II diabetes, with activation of pancreatic GLP-1Rs eliciting glucose-dependent insulin secretion. Currently, approved therapeutics acting at this receptor are peptide based, and there is substantial interest in small molecule modulators for the GLP-1R. Using a variety of resonance energy transfer techniques, we demonstrate that the GLP-1R forms homodimers and that transmembrane helix 4 (TM4) provides the primary dimerization interface. We show that disruption of dimerization using a TM4 peptide, a minigene construct encoding TM4, or by mutation of TM4, eliminates G protein-dependent high-affinity binding to GLP-1(7-36)NH 2 but has selective effects on receptor signaling. There was <10-fold decrease in potency in cAMP accumulation or ERK1/2 phosphorylation assays but marked loss of intracellular calcium mobilization by peptide agonists. In contrast, there was near-complete abrogation of the cAMP response to an allosteric agonist, compound 2, but preservation of ERK phosphorylation. Collectively, this indicates that GLP-1R dimerization is important for control of signal bias. Furthermore, we reveal that two small molecule ligands are unaltered in their ability to allosterically modulate signaling from peptide ligands, demonstrating that these modulators act in cis within a single receptor protomer, and this has important implications for small molecule drug design.
New Criteria for Response to Treatment in Immunoglobulin Light Chain Amyloidosis Based on Free Light Chain Measurement and Cardiac Biomarkers: Impact on Survival Outcomes
Palladini, Giovanni , Dispenzieri, Angela , Kumar, Shaji , Wechalekar, Ashutosh , Hawkins, Philip N. , Schönland, Stefan , Comenzo, Raymond L. , Kastritis, Efstathios , Dimopoulos, Meletios Α. , Jaccard, Arnaud , Klersy, Catherine , Merlini, Giampaolo , Gertz, Morie A. , Wechalekar, Ashutosh D. , Hegenbart, Ute , Dispenzieri, Angela , Jaccard, Arnaud , Merlini, Giampaolo , Dimopoulos, Meletios A , Schönland, Stefan , Klersy, Catherine , Kastritis, Efstathios , Palladini, Giovanni

Journal of Clinical Oncology | October 23, 2012 | Volume: 30 | Issue: 36 | Pages: 4541-4549

10.1200/jco.2011.37.7614 | PMID 23091105 Get It

Purpose To identify the criteria for hematologic and cardiac response to treatment in immunoglobulin light chain (AL) amyloidosis based on survival analysis of a large patient population. Patients and Methods We gathered for analysis 816 patients with AL amyloidosis from seven referral centers in the European Union and the United States. A different cohort of 374 patients prospectively evaluated at the Pavia Amyloidosis Research and Treatment Center was used for validation. Data was available for all patients before and 3 and/or 6 months after initiation of first-line therapy. The prognostic relevance of different criteria for hematologic and cardiac response was assessed. Results There was a strong correlation between the extent of reduction of amyloidogenic free light chains (FLCs) and improvement in survival. This allowed the identification of four levels of response: amyloid complete response (normal FLC ratio and negative serum and urine immunofixation), very good partial response (difference between involved and uninvolved FLCs [dFLC] < 40 mg/L), partial response (dFLC decrease > 50%), and no response. Cardiac involvement is the major determinant of survival, and changes in cardiac function after therapy can be reliably assessed using the cardiac biomarker N-terminal natriuretic peptide type B (NT-proBNP). Changes in FLC and NT-proBNP predicted survival as early as 3 months after treatment initiation. Conclusion This study identifies and validates new criteria for response to first-line treatment in AL amyloidosis, based on their association with survival in large patient populations, and offers surrogate end points for clinical trials.
The Whole Life Prostate Book: Everything that Every Man—at Every Age—Needs to Know About Maintaining Optimal Prostate HealthCarterH.B. and CouzensG.S.: The Whole Life Prostate Book: Everything that Every Man—at Every Age—Needs to Know About Maintaining Opt
Myers, Robert P.

Journal of Urology | October 22, 2012 | Volume: 188 | Issue: 6 | Pages: 2444-2444

10.1016/j.juro.2012.09.066 Get It

Comparative Effectiveness for Survival and Renal Function of Partial and Radical Nephrectomy for Localized Renal Tumors: A Systematic Review and Meta-Analysis
Kim, Simon P. , Thompson, R. Houston, Boorjian, Stephen A. , Han, Leona C., Erwin, Patricia J., Costello, Brian A. , Chow, George K. , Leibovich, Bradley C. , Murad, M. Hassan , Weight, Christopher

Journal of Urology | October 22, 2012 | Volume: No volume available | Issue: 1 | Pages: No page available

10.1016/j.juro.2012.10.026 | PMID 23085064 Get It

Avascular Necrosis of the Scaphoid following a Scapholunate Screw: A Case Report
Vitale, Mark A. , Shin, Alexander Y. , Shin, Alexander Y

HAND | October 22, 2012 | Volume: 8 | Issue: 1 | Pages: 110-114

10.1007/s11552-012-9463-8 | PMID 24426905 Get It

Acute Proximal Row Carpectomy to Treat a Transscaphoid, Transtriquetral Perilunate Fracture Dislocation: Case Report and Review of the Literature
Huish, Eric G. , Vitale, Mark A. , Shin, Alexander Y. , Shin, Alexander Y

HAND | October 22, 2012 | Volume: 8 | Issue: 1 | Pages: 105-109

10.1007/s11552-012-9462-9 | PMID 24426904 Get It

Cell Migration after Synovium Graft Interposition at Tendon Repair Site
Hayashi, Masanori , Zhao, Chunfeng , An, Kai‐Nan , Amadio, Peter C.

HAND | October 22, 2012 | Volume: 7 | Issue: 4 | Pages: 374-379

10.1007/s11552-012-9453-x | PMID 24294156 Get It

Background We have recently reported that interpositional synovium grafts from tendon sheath have a potential to accelerate tendon healing when implanted at the repair site. The purpose of this study was to investigate the effect of orientation of the synovium after synovium graft transplantation, by comparing the ability of cells from the visceral and parietal surfaces to migrate into the tendon in a canine tissue culture model. Methods The synovium graft was placed within a complete tendon laceration, with either the visceral or parietal surface facing the proximal end of the lacerated tendon. The number of migrating cells was quantified by a cell migration assay. Qualitative immunohistochemistry and confocal laser microscopy were also used at day 10. Results Many labeled synovial cells were observed within the tendon to which the visceral surface of the synovium graft was facing. Migrated cells were also observed on the parietal side, but there were fewer cells compared to visceral surface cells. Migrating cells all expressed α-smooth muscle actin. Conclusion We found that graft orientation affected cell migration. Whether this finding has clinical significance awaits in vivo study.
Grip strength in CIDP: does one function fit all?
Dimberg, Elliot L.

European Journal of Neurology | October 22, 2012 | Volume: 20 | Issue: 5 | Pages: 733-734

10.1111/ene.12007 | PMID 23083297 Get It

Click here to view the accompanying paper in this issue.
Benign Breast Disease and the Risk of Subsequent Breast Cancer in African American Women
Alosh, Barra, Kim, Elizabeth , Albashiti, Bassam, Sharaf, Aldeen Bashar, Frost, Marlene H., Visscher, Daniel W., Hartmann, Lynn C. , Nassar, Warzecha Hind, Ali-Femhi, Rouba, Coté, Michele L. , Ruterbusch, Julie J. , Bandyopadhyay, Subhayu , Radisky, Derek C.

Cancer Prevention Research | October 19, 2012 | Volume: 5 | Issue: 12 | Pages: 1375-1380

10.1158/1940-6207.capr-12-0175 | PMID 23087047 Get It

Abstract Benign breast disease (BBD) is an established risk factor for breast cancer among Caucasian women but less is known about BBD in African American women. As African American women suffer from disproportionate mortality due to breast cancer, special focus on pathologic characteristics that may influence disease risk is warranted. Benign breast biopsies from African American women were identified by the University Pathology Group (Detroit, MI). African American women of ages 20 to 84 years, who underwent a breast biopsy from 1997 to 2000, were eligible for the study. Subsequent breast cancers were identified through a linkage with the Detroit Surveillance Epidemiology and End Results (SEER) program. The first biopsy was reviewed by the pathologist, and lesions were classified following Dupont and Page criteria along with involution and other histologic features. Logistic regression was used to estimate the risk of developing a subsequent breast cancer with the histologic characteristics of BBD. A total of 1,406 BBD biopsies from African American women were included in this study with a median follow-up of 10.1 years. The majority (68%) showed nonproliferative disease, 29% had proliferative disease without atypia, and 3% had proliferative disease with atypia. Subsequent incident breast cancers occurred in 55 women (3.9%). Women whose biopsies showed proliferative disease with atypia were more than three-fold more likely to develop breast cancer as compared with women who had nonproliferative disease [relative risk (RR) 3.29, 95% confidence interval (CI) 1.21–8.93]. Better characterization of the risk of breast cancer among women with BBD, considering both ethnicity and detailed molecular findings, can lead to better surveillance, earlier diagnosis, and potentially improved survival. Cancer Prev Res; 5(12); 1375–80. ©2012 AACR.
Comment on “Expansion of Effector Memory Regulatory T Cells Represents a Novel Prognostic Factor in Lower Risk Myelodysplastic Syndrome”
Gangat, Naseema , Patnaik, Mrinal M.

The Journal of Immunology | October 19, 2012 | Volume: 189 | Issue: 9 | Pages: 4199-4199

10.4049/jimmunol.1290063 | PMID 23087423 Get It